Nebulized Albuterol for Congestive Heart Failure Exacerbation

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized trial of the use of Albuterol in the setting of acute decompensated Congestive Heart Failure with radiographic evidence of Cardiogenic Pulmonary Edema.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Treatments: Albuterol

Criteria

Inclusion Criteria:

• age 18-65 with shortness of breath and history of CHF

• pulmonary edema on chest xr

Exclusion Criteria:

• pregnancy

• clinical or ekg changes to suggest acute coronary syndrome

• history of copd or asthma

• history of albuterol on medication list